产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
CI-1044 | C647932-5mg | ≥98% | 197894-84-1 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
CI-1044 | C647932-50mg | ≥98% | 197894-84-1 | 50mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
CI-1044 | C647932-10mg | ≥98% | 197894-84-1 | 10mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
CI-1044 | C647932-100mg | ≥98% | 197894-84-1 | 100mg | ¥ 22500.9 | 期货,请咨询 | 阿拉丁 |
CDK12-IN-3 | C647924-5mg | ≥99% | 2220184-50-7 | 5mg | ¥ 4500.9 | 期货,请咨询 | 阿拉丁 |
CDK12-IN-3 | C647924-50mg | ≥99% | 2220184-50-7 | 50mg | ¥ 25500.9 | 期货,请咨询 | 阿拉丁 |
CDK12-IN-3 | C647924-25mg | ≥99% | 2220184-50-7 | 25mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 |
CDK12-IN-3 | C647924-10mg | ≥99% | 2220184-50-7 | 10mg | ¥ 7500.9 | 期货,请咨询 | 阿拉丁 |
CDK12-IN-3 | C647924-100mg | ≥99% | 2220184-50-7 | 100mg | ¥ 43500.9 | 期货,请咨询 | 阿拉丁 |
CLK8 | C647919-5mg | 898920-65-5 | 5mg | ¥ 2500.9 | 期货,请咨询 | 阿拉丁 | |
CLK8 | C647919-50mg | 898920-65-5 | 50mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 | |
CLK8 | C647919-25mg | 898920-65-5 | 25mg | ¥ 9200.9 | 期货,请咨询 | 阿拉丁 | |
CLK8 | C647919-10mg | 898920-65-5 | 10mg | ¥ 4200.9 | 期货,请咨询 | 阿拉丁 | |
Carvedilol-d4 | C647910-5mg | ≥99% | 1133705-56-2 | 5mg | ¥ 8800.9 | 期货,请咨询 | 阿拉丁 |
Carvedilol-d4 | C647910-1mg | ≥99% | 1133705-56-2 | 1mg | ¥ 2900.9 | 期货,请咨询 | 阿拉丁 |
Carvedilol-d4 | C647910-10mg | ≥99% | 1133705-56-2 | 10mg | ¥ 14500.9 | 期货,请咨询 | 阿拉丁 |
CNX-1351 | C647904-5mg | ≥99% | 1276105-89-5 | 5mg | ¥ 1200.9 | 期货,请咨询 | 阿拉丁 |
CNX-1351 | C647904-50mg | ≥99% | 1276105-89-5 | 50mg | ¥ 6600.9 | 期货,请咨询 | 阿拉丁 |
CNX-1351 | C647904-10mg | ≥99% | 1276105-89-5 | 10mg | ¥ 1900.9 | 期货,请咨询 | 阿拉丁 |
CNX-1351 | C647904-100mg | ≥99% | 1276105-89-5 | 100mg | ¥ 10500.9 | 期货,请咨询 | 阿拉丁 |
CPA inhibitor | C647897-5mg | ≥99% | 223532-02-3 | 5mg | ¥ 2600.9 | 期货,请咨询 | 阿拉丁 |
CPA inhibitor | C647897-50mg | ≥99% | 223532-02-3 | 50mg | ¥ 9000.9 | 期货,请咨询 | 阿拉丁 |
CPA inhibitor | C647897-10mg | ≥99% | 223532-02-3 | 10mg | ¥ 3400.9 | 期货,请咨询 | 阿拉丁 |
CZL55 | C647896-1mg | ≥98% | 667408-87-9 | 1mg | ¥ 800.9 | 期货,请咨询 | 阿拉丁 |